QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
Last update: 3/19/2008 3:34:00 PM
NEW YORK, March 19, 2008 /PRNewswire via COMTEX/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.
Autoimmune-Inflammation Index (HHA) Drop GW Pharmaceuticals, Inc (LSE: GWP.L) Human Genome Sciences (HGSI) Ligand Pharmaceuticals, Inc. (LGND) Add Fornix Biosciences N.V. (Amsterdam: FORBI.AS) Meda AB (SHSE1: MEDA A) Mitsubishi Tanabe Pharma Corporation (TSE: 4508) Cancer Index (HHK) Drop Shire PLC (SHPGY) Add Ark Therapeutics Group Plc (LSE: AKT.L) Cardio Devices Index (HHE) Drop Biosphere Medical, Inc. (BSMD) Add Zoll Medical Corp. (ZOLL) Cardiology Index (HRD) Drop Encysive Pharmaceuticals, Inc. (ENCY) Human Genome Sciences, Inc (HGSI) Vical, Inc (VICL) Add Mitsubishi Tanabe Pharma Corporation (TSE: 4508) Sangamo BioSciences Inc (SGMO) Sciele Pharma, Inc. (SCRX) Composite Index (HHQ) Drop Advanced Medical Optics, Inc. (EYE) Align Technology Inc. (ALGN) Array Biopharma Inc. (ARRY) ArthroCare Corp. (ARTC) Endo Pharmaceuticals Hldgs. (ENDP) Fresenius Medical Care AG (XETRA: FME.DE) GEDEON RICHTER RT (XETRA: R1G1.DE) GENMAB A/S (Copenhagen: GEN.CO) H. LUNDBECK A/S (Copenhagen: LUN.CO) Human Genome Sciences (HGSI) Imclone Systems (IMCL) Inverness Medical Innovations (IMA) Invitrogen Corp. (IVGN) Medarex Inc. (MEDX) Medicis Pharmaceutical (MRX) Mentor Corp. (MNT) ONYX Pharmaceuticals Inc. (ONXX) PDL BioPharma, Inc. (PDLI) Pharmion Corp. (PHRM) Progenics Pharmaceuticals Inc. (PGNX) Regeneron Pharmaceuticals (REGN) Respironics Inc. (RESP) Sepracor Inc. (SEPR) Theravance Inc. (THRX) United Therapeutics Corp. (UTHR) Valeant Pharmaceuticals Int'l (VRX) Vertex Pharmaceuticals (VRTX) Add Adolor Corp. (ADLR) ALLOS THERAPEUTICS INC. (ALTH) Alnylam Pharmaceuticals Inc. (ALNY) Alpharma Inc. (ALO) Altus Pharmaceuticals Inc. (ALTU) AMAG Pharmaceuticals Inc. (AMAG) ANGIOTECH PHARMACEUTICALS (ANPI) Ark Therapeutics (LSE: AKT.L) Bavarian Nordic A/S (Copenhagen: BAVA.CO) Caraco Pharmaceutical Laboratories Ltd. (CPD) Cardiome Pharma Corp. (CRME) Coventry Health Care Inc. (CVH) CRUCELL-ADR (CRXL) CUBIST PHARMACEUTICALS INC. (CBST) Discovery Laboratories Inc. (DSCO) Eisai Co. Ltd. (TSE: 4523.T) Encysive Pharmaceuticals Inc. (ENCY) Enzo Biochem Inc. (ENZ) ENZON PHARMACEUTICALS INC. (ENZN) Exelixis Inc. (EXEL) Flamel Technologies (FLML) Illumina Inc. (ILMN) Incyte Corporation (INCY) Integra LifeSciences Holdings (IART) Meda AB (Stockholm: MEDAA.ST) Mitsubishi Tanabe Pharma (TSE: 4508.T) Taisho Pharmaceutical Co., Ltd. (TSE: 4535.T) Dermatology and Wound Index (HRW) Drop Shire PLC (ADR) (SHPGY) SkyePharma Plc (LSE: SKP.LN) Add Standard Chemical & Pharm. Co., Ltd. (TSE: 1720) Taisho Pharmaceutical Co., Ltd. (TSE: 4535) Diagnostics Index (HHD) Drop CR Bard, Inc. (BCR) IDEXX Laboratories (IDXX) Add Bruker Corporation (BRKR) Halozyme Therapeutic (HALO) Emerging Cancer Index (HHJ) Drop Adventrx Pharmaceuticals, Inc. (ANX) Keryx Biopharmaceuticals, Inc. (KERX) Add Dyanvax Technologies (DVAX) Synta Pharmaceuticals Corp. (SNTA) Enabling Technologies Index (HHV) Drop Hillenbrand Industries (HB) Add Eurand N.V. (EURX) GI/Gender Index (HHU) Drop AEterna Zentaris (AEZS) King Pharmaceuticals (KG) Nastech Pharmaceutical (NSTK) Add Columbia Laboratories Inc. (CBRX) Eisai Co. Ltd. (Tokyo Stock Exchange: 4523) Mylan, Inc. (MYL) Metabolic-Endocrine Disorders Index (HHM) Drop Depomed Inc. (DEPO) Emisphere Technologies Inc. (EMIS) Flamel Technologies SA ADS (FLML) Hospira Inc. (HSP) Human Genome Sciences, Inc. (HGSI) Indevus Pharmaceuticals Inc. (IDEV) Ipsen Ltd. (Paris: IPN.PR) Nastech Pharmaceutical Co. (NSTK) Nektar Therapeutics (NKTR) NicOx S.A. (Paris: NCOX) OSI Pharmaceuticals Inc. (OSIP) ProStrakan Group Plc (LSE: PSK.L) Solvay S.A. (Brussels: SVYSY) Add Altus Pharmaceuticals Inc. (ALTU) Amicus Therapeutics, Inc. (FOLD) Biodel Inc. (BIOD) CombinatoRx Inc. (CRXX) GW Pharmaceuticals Plc (LSE: GWP.L) Incyte Corp. (INCY) Orexigen Therapeutics, Inc. (OREX) Repros Therapeutics Inc. (RPRX) Sangamo BioSciences Inc. (SGMO) Sirtris Pharmaceuticals, Inc. (SIRT) SuperGen Inc. (SUPG) Transition Therapeutics Inc. (TTHI) XOMA Ltd. (XOMA) Neuroscience Index (HHN) Drop Neurochem Inc. (NRMX) Add Caraco Pharmaceutical Laboratories Ltd. (CPD) Ophthalmology Index (HHZ) Drop Insite Vision Inc. (ISV) Add King Pharmaceuticals (KG) Patient Care Services Index (HHB) Drop Fresenius Medical Care (XETRA: FME.DE) Add Coventry Health Care Inc. (CVH)The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008. In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at . About QED International Associates QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at SOURCE QED International Associates Inc.
Copyright (C) 2008 PR Newswire. All rights reserved